Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice

Neuroscience

Volumn 177, Issue , 2011, Pages 223-229

  Ortiz, A N ^a   Oien, D B ^a,b   Moskovitz, J ^a   Johnson, M A ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

Author keywords

Amphetamine; Cocaine; Dopamine; Methionine sulfoxide reductase; Reserve pool; Voltammetry

Indexed keywords

AMPHETAMINE; CALCIUM; CARBON FIBER; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHIONINE SULFOXIDE REDUCTASE A; METIROSINE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; EXOCYTOSIS; EXTRACELLULAR CALCIUM; MICROELECTRODE; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STRIATE CORTEX; WILD TYPE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; METHIONINE SULFOXIDE REDUCTASES; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES;

EID: 79952009445     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.001     Document Type: Article

References (44)

1. Bartlett R.K., Bieber Urbauer R.J., Anbanandam A., Smallwood H.S., Urbauer J.L., Squier T.C. Oxidation of Met144 and Met145 in calmodulin blocks calmodulin dependent activation of the plasma membrane Ca-ATPase. Biochemistry 2003, 42:3231-3238.
2. Bigelow D.J., Squier T.C. Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim Biophys Acta 2005, 1703:121-134.
3. Bird E.D., Iversen L.L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 1974, 97:457-472.
4. Borges S., Gleason E., Turelli M., Wilson M. The kinetics of quantal transmitter release from retinal amacrine cells. Proc Natl Acad Sci U S A 1995, 92:6896-6900.
5. Chen B.T., Avshalumov M.V., Rice M.E. H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release. J Neurophysiol 2001, 85:2468-2476.
6. Chiueh C.C., Moore K.E. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. J Pharmacol Exp Ther 1975, 192:642-653.
7. Cohen G. The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm Suppl 1983, 19:89-103.
8. Cremona O., De Camilli P. Synaptic vesicle endocytosis. Curr Opin Neurobiol 1997, 7(3):323-330.
9. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., Bartlett R.K., Lowe J.S., O'Donnell S.E., Aykin-Burns N., Zimmerman M.C., Zimmerman K., Ham A.J., Weiss R.M., Spitz D.R., Shea M.A., Colbran R.J., Mohler P.J., Anderson M.E. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
10. Fischer J.F., Cho A.K. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 1979, 208:203-209.
11. Fox A.P., Currie K.P.M. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. J Neurosci 1997, 17:4570-4579.
12. Gomis A., Burrone B., Lagnado L. Two actions of calcium regulate the supply of releasable vesicles at the ribbon synapse of retinal bipolar cells. J Neurosci 1999, 19:6309-6317.
13. Heuser J.E., Reese T.S. Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J Cell Biol 1973, 57(2):315-344.
14. Johnson M.A., Rajan V., Miller C.E., Wightman R.M. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem 2006, 97:737-746.
15. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998, 18:1979-1986.
16. Kavalali E.T. Synaptic vesicle reuse and its implications. Neuroscientist 2006, 12(1):57-66.
17. Kraft J.C., Osterhaus G.L., Ortiz A.N., Garris P.A., Johnson M.A. In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience 2009, 161:940-949.
18. Kume-Kick J., Rice M.E. Dependence of dopamine calibration factors on media Ca2+ and Mg2+ at carbon-fiber microelectrodes used with fast-scan cyclic voltammetry. J Neurosci Methods 1998, 84:55-62.
19. Liang N.Y., Rutledge C.O. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 1982, 31:2479-2484.
20. Michaelis M.L., Bigelow D.J., Schoneich C., Williams T.D., Ramonda L., Yin D., Huhmer A.F., Yao Y., Gao J., Squier T.C. Decreased plasma membrane calcium transport activity in aging brain. Life Sci 1996, 59:405-412.
21. Morgan D.G., May P.C., Finch C.E. Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease. J Am Geriatr Soc 1987, 35:334-345.
22. Moskovitz J. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta 2005, 1703:213-219.
23. Moskovitz J. Prolonged selenium-deficient diet in MsrA knockout mice causes enhanced oxidative modification to proteins and affects the levels of antioxidant enzymes in a tissue-specific manner. Free Radic Res 2007, 41:162-171.
24. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 2001, 98:12920-12925.
25. Nachshen D.A., Sanchez-Armass S. Co-operative action of calcium ions in dopamine release from rat brain synaptosomes. J Physiol 1987, 387:415-423.
26. Neves G., Lagnado L. The kinetics of exocytosis and endocytosis in the synaptic terminal of goldfish retinal bipolar cells. J Physiol 1999, 515(Pt 1):181-202.
27. Oien D.B., Moskovitz J. Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr Top Dev Biol 2008, 80:93-133.
28. Oien D., Wang X., Moskovitz J. Genomic and proteomic analyses of the methionine sulfoxide reductase A knockout mouse. Curr Proteomics 2008, 5:96-103.
29. Oien D.B., Ortiz A.N., Rittel A.G., Dobrowsky R.T., Johnson M.A., Levant B., Fowler S.C., Moskovitz J. Dopamine D2 receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse. J Neurochem 2010, 114(1):51-61.
30. Oien D.B., Osterhaus G.L., Latif S.A., Pinkston J.W., Fulks J., Johnson M., Fowler S.C., Moskovitz J. MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic Biol Med 2008, 45:193-200.
31. Oien D.B., Osterhaus G.L., Lundquist B.L., Fowler S.C., Moskovitz J. Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse. Neurosci Lett 2010, 468:38-41.
32. Oien D.B., Shinogle H.E., Moore D.S., Moskovitz J. Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci 2009, 39:323-332.
33. Ortiz A.N., Kurth B.J., Osterhaus G.L., Johnson M.A. Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum. J Neurochem 2010, 112:755-761.
34. Outeiro T.F., Klucken J., Bercury K., Tetzlaff J., Putcha P., Oliveira L.M., Quintas A., McLean P.J., Hyman B.T. Dopamine-induced conformational changes in alpha-synuclein. PLoS One 2009, 4:e6906.
35. Pal R., Oien D.B., Ersen F.Y., Moskovitz J. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res 2007, 180:765-774.
36. Palacios J., Sepulveda M.R., Lee A.G., Mata A.M. Ca2+ transport by the synaptosomal plasma membrane Ca2+-ATPase and the effect of thioridazine. Biochemistry 2004, 43:2353-2358.
37. Patten D.A., Germain M., Kelly M.A., Slack R.S. Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 2010, 20(Suppl 2):S357-S367.
38. Perez-Severiano F., Santamaria A., Pedraza-Chaverri J., Medina-Campos O.N., Rios C., Segovia J. Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation. Neurochem Res 2004, 29:729-733.
39. Rizzoli S.O., Betz W.J. Synaptic vesicle pools. Nat Rev Neurosci 2005, 6:57-69.
40. Rose S.D., Lejen T., Casaletti L., Larson R.E., Pene T.D., Trifaro J.M. Molecular motors involved in chromaffin cell secretion. Ann N Y Acad Sci 2002, 971:222-231.
41. Venton B.J., Seipel A.T., Phillips P.E., Wetsel W.C., Gitler D., Greengard P., Augustine G.J., Wightman R.M. Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 2006, 26:3206-3209.
42. Yavich L., Oksman M., Tanila H., Kerokoski P., Hiltunen M., van Groen T., Puolivali J., Mannisto P.T., Garcia-Horsman A., MacDonald E., Beyreuther K., Hartmann T., Jakala P. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Neurobiol Dis 2005, 20:303-313.
43. Yavich L., Tanila H., Vepsalainen S., Jakala P. Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci 2004, 24:11165-11170.
44. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu Rev Physiol 2002, 64:355-405.